Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders (PRPPOR)

Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile

Accepts healthy volunteers
intracytoplasmic sperm injection
paracentesis
transvaginal ultrasound
ovarian stimulation
  • 0 views
  • 25 Apr, 2022
  • 1 location
Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation (OPIF)

The primary objective is to investigate the efficacy, defined as an increase in oocyte numbers upon ovarian stimulation, and safety of a single intra-ovarian PRP injection vs. saline solution

  • 0 views
  • 27 Apr, 2022
  • 1 location
Preimplantation Genetic Screening in Patients With Male Factor Infertility

participants will receive the same protocol for ovarian stimulation and standardized luteal phase support. The target population will be patients with severe male-factor infertility aged between 20 and

  • 0 views
  • 16 Jun, 2022
  • 1 location
Double Stimulation Followed by a Fresh Embryo Transfer (DUO_STIM_FRESH)

The major goal of controlled ovarian stimulation (COS) is to increase the number of oocytes harvested in order to result in the generation of a higher number of available embryos, extended

oocyte retrieval
ovarian hyperstimulation syndrome
progesterone
embryo transfer
ovarian hyperstimulation
  • 23 views
  • 21 Apr, 2022
  • 1 location
Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment

ovarian tissue cryopreservation can be proposed to prepubertal girls with a high risk of infertility. For pubertal patient, cryopreservation of mature oocytes after ovarian stimulation can be offered if

fertility preservation
cancer treatment
  • 1 views
  • 20 Aug, 2021
  • 2 locations
Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients (SALIVA_MINT)

, is an important part of ovarian stimulation, requiring patients to undergo multiple blood draws. It is often a physically and emotionally painful process and the most convenient solution to this

progesterone
embryo transfer
  • 0 views
  • 22 Mar, 2022
  • 1 location
Effects of Immunomodulatory Therapy on Gonadal Function in Women With Autoimmune Premature Ovarian Insufficiency

in response to ovarian stimulation. Secondary outcomes: Reestablishment of spontaneous menstrual bleedings during the 12 months' study period Ovulation during the 12

  • 0 views
  • 23 Oct, 2022
Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support

Hormonal milieu during implantation is crucial to embryo-endometrium interaction and to the viability of the conceptus. Alterations in the peri-implantation environment are considered to impair perinatal outcomes in intracytoplasmic sperm injection (ICSI) therapy. GnRH-a is a new and promising modality for LPS. Regimens for using GnRH-a in LPS, including single …

gonadotrophin releasing hormone analogue
oocyte retrieval
intracytoplasmic sperm injection
progesterone
follicle stimulating hormone
  • 0 views
  • 21 Apr, 2022
  • 1 location
HYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become Pregnant (AGNOHSTIC)

To compare the costs and effects of HYALOBARRIER GEL ENDO versus no HYALOBARRIER GEL ENDO for increasing the chance of conception leading to live birth measured at 30 weeks after randomization in women wishing to become pregnant after surgical removal of intrauterine pathology (endometrial polyps, fibroids with uterine cavity deformation, …

uterine adhesions
myoma
intracytoplasmic sperm injection
icsi
intrauterine insemination
  • 21 views
  • 06 Feb, 2022
  • 1 location
GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth

In the study the investigators would like to examine the effect of GnRH antagonist administration at the beginning of the follicular phase in patients presenting with high baseline estradiol levels of 200 pmol/L or above with a leading follicle of 11-13 mm. In the unit's practice, patients presenting for cycle …

gnrh antagonist
estradiol
antral
follicle stimulating hormone
ganirelix
  • 0 views
  • 16 Oct, 2021
  • 1 location